» Articles » PMID: 7243210

3. Phenylephrine Hydrochloride

Overview
Journal Ophthalmology
Publisher Elsevier
Specialty Ophthalmology
Date 1980 Nov 1
PMID 7243210
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Phenylephrine hydrochloride is a potent, effective, relatively safe drug with few ocular side effects. Side effects from topical instillation are uncommon but include severe systemic cardiovascular effects with elevated blood pressure and stroke. Ten percent phenylephrine should be used with caution in patients with known cardiac disease, hypertension, aneurysms, long-standing insulin-dependent diabetes, or advanced arteriosclerosis. A 2.5% concentration is generally indicated for ophthalmic examination as well as for use in infants and in the elderly. Phenylephrine should not be used in patients with narrow-angle glaucoma, and it is also contraindicated in patients taking monoamine oxidase inhibitors or tricyclic antidepressants.

Citing Articles

Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases.

Titz B, Siebourg-Polster J, Bartolo F, Lavergne V, Jiang Z, Gayan J Transl Vis Sci Technol. 2024; 13(6):17.

PMID: 38913008 PMC: 11205237. DOI: 10.1167/tvst.13.6.17.


Pupillary Dilation in Research: More than Meets the Eye.

Szpernal J, Bachman Groth J, Wynne N, Williams V, Spellecy R, Thuruthumaly C Curr Eye Res. 2022; 47(7):965-977.

PMID: 35499263 PMC: 9276640. DOI: 10.1080/02713683.2022.2053723.


Characterizing Current Attitudes and Practices for Human Subject Safety in Studies Involving Pupil Dilation.

Szpernal J, Carroll J, Spellecy R, Bachman Groth J J Empir Res Hum Res Ethics. 2020; 16(1-2):54-64.

PMID: 33135560 PMC: 8035129. DOI: 10.1177/1556264620968989.


Over-the-Counter Ocular Decongestants in the United States - Mechanisms of Action and Clinical Utility for Management of Ocular Redness.

Hosten L, Snyder C Clin Optom (Auckl). 2020; 12:95-105.

PMID: 32801982 PMC: 7399465. DOI: 10.2147/OPTO.S259398.


Budget impact model of Mydrane®, a new intracameral injectable used for intra-operative mydriasis, from a UK hospital perspective.

Davey K, Chang B, Purslow C, Clay E, Vataire A BMC Ophthalmol. 2018; 18(1):104.

PMID: 29673317 PMC: 5907706. DOI: 10.1186/s12886-018-0746-x.